𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib

✍ Scribed by W.J. Lee; J.L. Lee; S.E. Chang; M.W. Lee; Y.K. Kang; J.H. Choi; K.C. Moon; J.K. Koh

Book ID
108670729
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
396 KB
Volume
161
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Electrophysiological signs and the preva
Electrophysiological signs and the prevalence of adverse effects of acetylcholinesterase inhibitors in patients with myasthenia gravis
✍ Anna Rostedt Punga; Mikio Sawada; Erik V. StΓ₯lberg πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 138 KB πŸ‘ 1 views

## Abstract The aim of this prospective study was to assess whether extra discharges (EDs), sometimes following the compound muscle action potential, could be used as a neurophysiological indicator of overdose of acetylcholinesterase inhibitors (AChEIs) in patients with myasthenia gravis (MG). The

Phase II study of sunitinib malate, a mu
Phase II study of sunitinib malate, a multitargeted tyrosine kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies: Leiomyosarcoma, liposarcoma and malignant fibrous histiocytoma
✍ S. Tariq Mahmood; Samuel Agresta; Carlos E. Vigil; Xiuhua Zhao; Gang Han; Gina D πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 French βš– 251 KB

## Abstract Soft tissue sarcomas (STS) represent a diverse group of histologic subtypes with targetable molecular alterations, often treated as a single disease. Sunitinib malate is a multitargeted receptor tyrosine kinase inhibitor active in other solid tumors carrying similar alterations (__i.e._

Molecular diagnosis and monitoring in th
Molecular diagnosis and monitoring in the clinical management of patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors
✍ Joyce Ou; Jo-Anne Vergilio; Adam Bagg πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 161 KB πŸ‘ 2 views

## Abstract The well‐established molecular pathogenesis of chronic myelogenous leukemia (CML) and its consequences for laboratory testing and clinical management illustrate a classic paradigm for the importance of molecular diagnostics in targeted drug therapy. The success of the tyrosine kinase in